-

UK CoRep, FinRep and Capital Adequacy Training: Common Reporting Framework (COREP) and Financial Reporting Framework (FINREP) Frameworks (ONLINE EVENT: June 26, 2025) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CoRep, FinRep and Capital Adequacy" training has been added to ResearchAndMarkets.com's offering.

The course will focus on the practical reporting aspects of Common Reporting Framework (COREP) and Financial Reporting Framework (FINREP), as standardised reporting frameworks mandated by the EU EBA, and the UK PRA/FCA under the Capital Requirements Regulation (CRR). These frameworks ensure consistent and accurate reporting of financial and prudential information, enabling regulators to assess the stability and risk profiles of financial institutions.

The session covers the key challenges encountered by banks and credit institutions, and other investment firms asset managers and hedge funds, key lessons learnt in implementing trade and transaction reporting, and successful remediation of any issues.

This workshop covers all aspects of Financial reporting, from organisational scope, to data validation, data sourcing, data templates and structures, submission methodologies - and resulting impact to Front, Middle and Back Office processes.

Through interactive sessions, case studies, and hands-on exercises, participants will gain the knowledge and skills required to navigate the complexities of financial reporting in a regulated environment.

The course includes regulatory guidance from the PRA/FCA, EBA and local European regulators - and UK Financial reporting post Brexit.

What will you learn

By the end of this practical training you will:

  • Understand the Regulatory Background - Purpose, Scope and Imperatives for Financial Reporting using COREP and FINREP within UK and EU Banking Regulations (Basel III, CRD IV, CRR)
  • Master Reporting frameworks for COREP and FINREP, including the data structure, key templates, and data requirements
  • Develop practical skills in implementing and reporting Prudential Reporting (COREP) and Financial Reporting (FINREP) frameworks, using case studies and real life examples

Who Should Attend:

  • Treasury
  • Finance
  • Risk
  • Compliance
  • Audit
  • Financial Operations and Reporting
  • FP&A
  • Regulatory Affairs

Key Topics Covered:

  • Regulatory Capital and Basel 3.1/CRD IV/UK CRR
  • Pillar 1,2,3 reporting, ICAAP and ILAAP
  • Common Reporting Standards (COREP) - Regulatory Capital Reporting
  • Financial Reporting Standards (FINREP) - IFRS Financial Reporting
  • Next Steps and Upcoming Regulations (Basel 3.1 "Endgame")

For more information about this training visit https://www.researchandmarkets.com/r/djm7bi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein engineering to understand how to advance therapeutic development and industrial applications. Protein-based therapeutics have significantly advanced and created new paradigms in disease treatment. Half of the top ten selling drugs in 2023 were protein-based therapeutics. Pro...

Development of Combination Products: 2 Day Critical Interactions Training Course (Feb 9th - Feb 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of Combination Products: Critical Interactions Training Course (Feb 9th - Feb 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. The programme will cover the regulatory strategy to adopt and the relevant aspects of GMP and quality processes, including the data expectations for the CTD. It will also review the key relationships between quality, regulatory, R&D and production. Delegates will find this a comprehensive overview o...

Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR. The format for the d...
Back to Newsroom